LINQ: The integrated automation platform for early drug discovery

Lead generation

• Automata’s platform can facilitate the high-throughput screening process, including the automated preparation of assay plates.
• Compound management, storage, and retrieval can be automated to accelerate lead generation. When this is integrated into the assay platform, there is more robust sample tracking and data management.
• Automated liquid handling can optimise cell-based assays for lead identification. Larger numbers of assay plates can be handled and tracked, giving bigger, more complete data sets. Assays can be run out of hours for faster throughput. 

Lead optimisation

• Automata’s platform maximises the optimisation of lead compounds by automating cell-based assays and high-content screening.
• Automated preparation of assay-ready plates and tissue culture processes ensures efficiency. Automation can generate more assay-ready plates faster and more reliably than manual workflows.

Process development

• Automation streamlines analytical chemistry processes, including data analysis and reporting.
• Tissue culture processes, such as media changes and cell maintenance, can be automated and iterated for optimisation.

Formulation

• Automated QC systems ensure precise and consistent upstream and downstream process compliance in the preparation and manufacture of drug formulations.

Investigational new drug applications

• Automata's platform can help manage the data and documents required for IND applications. It ensures accurate and efficient data collection and reporting to regulatory agencies, facilitating the final step in the pre-clinical phase. LINQ has full data and sample tracking, and an audit trail for data integrity.